ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
Washington University School of Medicine
Washington University School of Medicine
Shanghai JMT-Bio Inc.
ImmunityBio, Inc.
AbbVie
OncoC4, Inc.
Fox Chase Cancer Center
Inspirna, Inc.
Jeroen Bosch Ziekenhuis
First People's Hospital of Hangzhou
Western Regional Medical Center
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
University Hospital of Crete
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
GlaxoSmithKline
Case Comprehensive Cancer Center